Scott J. Warchal
London, ENG NW11AT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.
Journal: The Journal of infection
Published: July 18, 2025
EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers.
Journal: Nature communications
Published: June 26, 2024
Antibacterial activity of Au(I), Pt(II), and Ir(III) biotin conjugates prepared by the iClick reaction: influence of the metal coordination sphere on the biological activity.
Journal: Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry
Published: June 20, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.
Journal: The Lancet. Infectious diseases
Published: April 11, 2024
SARS-CoV-2 mucosal neutralising immunity after vaccination.
Journal: The Lancet. Infectious diseases
Published: August 25, 2023
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection.
Journal: The Lancet. Infectious diseases
Published: April 06, 2023
Three-dose vaccination elicits neutralising antibodies against omicron.
Journal: Lancet (London, England)
Published: December 29, 2021
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
Journal: Lancet (London, England)
Published: June 14, 2021
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
Journal: Lancet (London, England)
Published: May 29, 2021
Drug Screening Platforms and RPPA.
Journal: Advances in experimental medicine and biology
Published: December 11, 2019
Last Updated: 09/26/2026